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The proviral insertion site in Moloney murine leukemia virus-1 (Pim1) kinase is overexpressed in many human 
cancer diseases. Inhibition of Pim1 kinase has been reported can suppress cell proliferation and induce apoptotic 
cell death, so that the protein could be chosen as drug target for the treatment of cancer. Citronellol and geraniol 
mainly contained  in citronella oil that’s one of  Indonesian natural products have bioactivity as antitumor agents, 
so that both of the compounds can be used as guiding compound to be developed as chemoprevention and 
chemotherapeutic agent compounds for cancer especially for leukemia cancer. In this research, sixteen 
citronellol and geraniol esters as an inhibitor of leukemia cancer designed were docked based on their interaction 
with leukemia receptor target of Pim1 kinase by using Molegro Virtual Docker (MVD). The result showed that 
the binding citronellol and geraniol esters to Pim1 kinase are more stable and better affinity than the binding 
between citronellol and geraniol, indicated by rerank score were lower than rerank score of citronellol/geraniol-
Pim1 kinase. The docking resulted in the four top-ranked compounds, namely, citronellyl caproate, citronellyl 
caprylate, geranyl caproate and geranyl caprylate with rerank score value from -182.560 to -189.822 KJ/mol. 
These compounds have hydrogen bonding with amino acid  residues of Lys 67 and Asp 186 of an active site of 
Pim1 kinase.  Based on Lipinski’s rule of five, among of the four top-ranked compounds, citronellyl caproate 
and geranyl caproate were predicted have potency as new chemopreventive and chemotherapeutic agents for 
leukemia anticancer candidates.  
 






Leukemia is the most prevalent cancer 
for children in the developed and the 
developing countries (Bernard and 
Christopher, 2014). The cancer treatment by 
surgery, radiation, chemotherapy and cancer 
drug usage has not shown satisfactory result 
yet so that the research and development of the 
drug for the cancer treatment is still very 
needed. The development of modern 
computational chemistry and computational 
biology plays a vital role in drug discovery 
process for diseases causing proteins such as 
cancer (Ravi et al., 2012; Arsianti et al., 2014). 
Today, the modern computational chemistry 
by molecular docking methods are widely used 
in the early stages of drug discovery, 
purposing to rank potential inhibitors as an 
alternative to the experiments in the laboratory. 
Molecular docking method can be used to 
simulate how the interaction of the compounds 
with a target proteins, predict chemical 
characters needed for drug activity and 
propose of drug candidate compounds that are 
potential to be synthesized and developed 
(Yanuar, 2012; Siswandono, 2015; Li et al., 
2011). 
The discovery and development of 
cancer drug either natural or synthetic drug 
from a natural product are expected to result in 
the drug with higher activity, lower toxicity, 
and more selectively. During the last few 
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decades, chemopreventive and 
chemotherapeutic compounds against various 
types of cancer have been isolated from some 
number of medicinal plants (Christodoulu et 
al., 2013, Mandal et al., 2012; Qurishi et al., 
2011; Cragg and Newman, 2013). Indonesian 
biodiversity has potential as a source of 
bioactive compounds as a chemopreventive 
and chemotherapeutic agent for cancer 
treatment. Citronella is an essential oil mainly 
found in Lemongrass plant, including in genus 
of Cymbapogon and family of Poaceae 
(Ganjewala, 2009). Indonesia is the third 
citronella oil producer in the world, after China 
and Vietnam. The major compounds in 
citronella oil are monoterpene compounds such 
as citronellol and geraniol reported have many 
bioactivities  that is as antimicrobial, 
antibacterial, antifungal, antiviral, antiparasitic, 
antioxidant and anti-inflammatory (Bayala et 
al., 2014; Madnooni et al., 2012; Cavar et al., 
2012; Sharma et al., 2009). Citronellol and 
geraniol also reported effective against 
malignant cell proliferation (Biblap and 
Jhinuk, 2013; Khan et al., 2013; Chen and 
Viljoen, 2010; Can and Buchbauer, 2010). The 
monoterpene compound is a novel class 
compound of cancer chemopreventive.   
Citronellol and geraniol mainly 
contained in citronella oil are multipotent, 
which have many bioactivities through 
different mechanisms and different types of 
receptors so that citronellol and geraniol could 
be become guiding compound to be developed 
as chemoprevention and chemotherapeutic 
agent compounds for cancer especially for 
leukemia cancer. Citronellol and geraniol have 
been reported have cytotoxic activity against 
human cancer leukemia (HL60) cells with the 
IC50 value of 50 and 30 g/mL, respectively 
(Raut and Karuppayil, 2014; Kumar et al., 
2008). The short and medium chain fatty acids 
were also reported  have bioactivity as 
antimicrobial, antifungal, antiviral  and 
potentially as antitumor agents (Narayanan et 
al., 2015; Fauser, 2014). Therefore the ester 
compounds derivative of citronellol and 
geraniol with fatty acids might be potential as 
leukemia anticancer.  
The inhibition of protein kinases by 
selective inhibitors has become a dominant 
therapeutic approach for many diseases 
especially well established for cancer and a 
standard of modern clinical oncology 
(Grassow et al., 2014; Garcia et al., 2014). The 
proviral insertion site in Moloney murine 
leukemia virus-1 (Pim1) kinase belongs to a 
novel class of serine/threonine kinases with 
biochemical features regulating various 
oncogenic pathways, such as cell cycle 
progression and apoptosis resistance. Pim1 
kinase is overexpressed in many human cancer 
diseases and has been associated with 
metastasis and overall treatment response. The 
experimental model study reported that 
inhibition of Pim1 kinase suppressed 
proliferation and migration cell, induced 
apoptotic cell death, and synergized with other 
chemotherapeutic agents so that Pim1 kinase is 
the preferential target for inhibition of the 
mitotic processing and can be chosen as drug 
target for the treatment of cancer (Gisele et al., 
2016; Tursynbay et al., 2016; Matthew et al., 
2015; Weirauch et al., 2013). Some 
compounds were reported to inhibit the 
activity of serine/threonine kinases of Pim1, 
such as imidazopyridazine, benzoimidazol, 
acylhydrazone, triazolopyridine, thiazolidine-
2,4-dione, pyridone, staurosporin, and 
bisindolylmaleimide (Merkel et al.,  2012). 
Generally, the inhibitor of Pim1 are aromatic 
compounds. In this research, the study of 
acyclic compounds, citronellol and geraniol 
esters as inhibitors of Pim1 would be carried 
out. Therefore, citronellol, geraniol and ester 
derivatives of both of the compounds designed 
and chosen as an inhibitor of Pim1 kinase for 
treatment of leukemia cancer by using 
molecular docking method. 
The purpose of the study is to find out 
Pim1 kinase inhibitor potential from citronellol 
and geraniol esters through analysis of binding 
free energy and hydrogen bonding interaction 
into Pim1. We conducted docking simulation 
to citronellol and geraniol esters as ligands into 
Pim1 as target receptor  using Molegro Virtual 
Docker (MVD). There are more than 60 
molecular docking software. Generally, the 
programs search the compounds with adequate 
and conformational space 
produce correct binding poses, but the score 
function is still need repairs. Thus, in general 
the assessment is truly objectively difficult to 
realize in comparing programs with one 
another, because of favoritism, the selection of 
test data is biased and the level difference 
proficiency in using different programs. Some 
of which have been used are: DOCK, FlexX, 
Glide, Gold, Autodock and Molegro Virtual 
Docker/MVD (Yanuar, 2012). Currently MVD 





is widely used for docking simulation studies, 
because besides being cheap and easy to use, 
MVD has an accuracy of up to 87%, while 
Glide 82%, Surflex 75% and FlexX 58% 
(Nogrady and Weaver, 2005 in Siswandono, 
2015. 
            
2. MATERIALS AND METHODS 
In this study, we designed citronellol 
and geraniol esters and docked these 
compounds as based on their interactions with 
Pim1-kinase by using MVD 6.0 under licence 
of 2013.6.0.0-2013-05-21 computer software 
application to determine the best compound as 
inhibitor leukemia cancer. Analysis and 
screening were based on molecular docking 
(rerank) score, affinity, and hydrogen 
interaction of binding between compounds and 
the target protein.  
Target protein was selected and 
downloaded from Protein Data Bank (PDB). 
The three- dimensional (3D) structure of the 
target protein of Pim1 kinase was also 
downloaded from PDB. The water and it’s 
cofactor of protein molecule from Pim1 are 
eliminated. Furthermore, the active ligand 
contained in the protein is extracted, and then 
the active ligand is imported back into protein 
with the optimation of the position of x, y, z 
and radius in the protein. Furthermore, it is 
docked and see the value of Root Mean Square 
Deviation (RMSD). The method is valid if the 
value of RMSD ≤ 2 (Gisele et al., 2016). The 
energy minimization of protein molecule was 
carried out using Amber v9 tools molecular 
dinamic (MD) software.  
The structure of citronellol, geraniol, 
and ester derivative of these compounds as 
ligands were prepared and designed using 
ChemBioDrawUltra 12.0 software, and then 
copied into chembiodraw ultra 3D software 
and minimized of the energy of the 
compounds. The result is stored with the file 
format mol2. The next stage is docking of the 
ligand of compounds designed into protein 
Pim1 which the ligand exist on the protein 
already replaced. The value must be the same 
like in the validation method. The docking 
process was repeated for 20 times. Docking 
simulations, hydrogen interaction, binding of 
ligand and target protein were performed and 
visualized using software MVD. 
(Kusumaningrum et al., 2014) 
 
 
3. RESULTS AND DISCUSSION 
According to the USA’s National 
Cancer Institute (NCI), murine leukemia 
(P388) cells is a tumour cells type that used a 
cytotoxic test protocol, which the test result 
using the cells is often used as base on test 
similar further in order to obtain a compound 
as candidate anticancer drug (Dykes et al., 
2008). Therefore in the previous study the in 
vitro cytotoxic activity test of citronellol and 
geraniol as starting compounds were carried 
out against murine leukemia (P388) cells using 
MTT method. The result showed that 
citronellol and geraniol have potential as 
inhibitor of leukemia cancer, indicated by 
these compounds active against P388 cells 
with IC50 values of 38.49 and 28.12 µg/mL 
(Widiyarti et al., 2016). Ester compounds 
derivative of citronellol and geraniol expected 
to have cytotoxic activity higher than 
citronellol and geraniol due to the 
hydrophobicity of these compounds.  
The eighteen compounds, including 
citronellol and geraniol, 16 of citronellol and 
geraniol esters designed using ChemBioDraw 
Ultra 12.0 software were prepared. The 
structure of citronellol and geraniol esters have 
been drawn on ChemBioDraw Ultra 12.0 
software and imported to the MVD workspace 
in ‘sdf’ format. In order to make accurate 
predictions, it is important that the imported 
structures have been properly prepared, that is, 
the atom connectivity and bond orders are 
correct and partial atomiccharges are assigned 
(Kusumaningrum et al., 2014). After that, the 
ester compounds designed were then docked 
on target protein of Pim1 kinase as the receptor 
target using MVD. The crystal structure of 
Pim1 kinase downloaded directly from PDB 
that is accessed through the URL: 
http://www.rcbs.org/pdb. Criteria for selection 
of a protein as target receptor include this 
protein has an acceptable resolution (<2.8 Å), 
derived from Homo sapiens, and complex with 
small molecule ligand.  
Pim1 kinase is part of the serine-
threonine protein kinases that play a role in 
apoptosis, metabolism, cycles, and migration 
of cells in tumor growth. Pim1 kinase is also 
overexpressed in several types of human 
cancers and it’s activity also reported as a 
promoter of carcinogenesis, so that it is 
postulated as a potential target of cancer 
therapy (Tursynbay et al., 2016; Matthew et 
al., 2015; Weirauch  et al., 2013). Pim1 
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downloaded from PDB with ID code of 5 wdr 
selected due to has a resolution of 2Å, 
descended from Homo sapiens and complexes 
with a small molecule ligand of [N-4-
(1R,3S,5S)-3-amino-5-methylcyclohexyl–
pyridine-3-yl-6-(2,6-difluorophenyl)-5-
fluoropicolinamide (5H7_401(A)]. To 
determine the binding site area, MVD using 
encryption cavity detection will automatically 
search for the best position and identify as a 
potential binding site that called as cavities or 
active sites.  
The structure of citronellol and 
geraniol esters that designed using ChemDraw 
Ultra 12.0 copied into ChemBioDraw Ultra 3D 
software, and minimized the energy of the 
compounds. The result was stored as mol2 file 
formats, and import into MVD workspace in 
sdf formats. Furthermore the compounds 
positioned as the ligands docked as an inhibitor 
of the receptor of Pim1 kinase to see the 
potential leukemia anticancer activity of the 
compounds.  
MVD has identified five different 
cavities in Pim1 kinase crystal structure and 
docking will be done in the cavity 1 of Pim1 
kinase as shown in Figure 1. The validation of 
docking methods with 20 repetitions was done 
to ensure the orientation and position of 
binding of the ligand of 5H7_401 (A) that 
bounded to the Pim1 kinase protein (Gisele et 
al., 2016).  The location of ligand of 5H7_401 
(A) is in the cavity 1 with volume of 155.136; 
surface of 437.76 with a radius of 13; X = -
41.56;Y = -2.57;  and Z = 2.48. The validation 
test showed that RMSD value of 0.396, so that 
this method can be said to be valid. 
Furthermore 18 compounds include 
citronellol, geraniol, 16 citronellol and geraniol 
ester compounds, and Artonin E as a standard 
anticancer be functioning as inhibitor ligands 
of Pim1 kinase, then docked to Pim1 kinase, 
which each ligand is determined the best 
position that indicated by docking (rerank) 
score. The value of rerank score of the docking 
results were assumed as free energy of the 
binding between the target receptor of protein 
and the inhibitor ligand. The negative value is 
greater indicates that the binding of ligand-
protein is more stable, which means that the 
interaction between protein and ligand could 
inhibit the performance of the receptor of 
protein Pim1 kinase.(Gisele et al., 2016). The 
rerank score of the best position of each the 
binding of ligand-protein are shown at Table 1 
and Table 2. 
Citronellol and geraniol esters possible 
have cytotoxic activity better and more selective 
than citronellol and geraniol are possible due the 
increasing hydrophobicity properties and binding 
energy affinity towards protein as a binding target. 
The transformation of citronellol and geraniol 
structural into citronellol and geraniol esters by 
extending the carbon atoms chain to improve the 
hydrophobicity properties in order to enhance the 
selectivity of cytotoxic activity of the compounds. 
The hydrophobic character of the compound is one 
important character for the drug to be able to pass 
through cell membranes and interact with the 
receptor. Changes substituents on the structure of 
the drug have a significant effect on the 
hydrophobic character and biological activity. In 
general, the increasing of the hydrophobicity of the 
compound would increase biological activity, cause 
the drug compound must pass through the 
hydrophobic barrier of a cell membrane to reach the 
target (Siswandono, 2015). In the in vitro test, 
although no barrier must be passed, the drug 
compound must interact with the target system such 
as proteins or enzymes as receptors which normally 
hydrophobic binding site active. Besides, the 
transformation of structure of citronellol and 
geraniol by extending the carbon atom chain into 
ester compounds to aim for increasing of steric 
interaction to improve the biological activity. 
Nevertheles, according to the Lipinski’s rule of 
five, generally the drug compound is as orally 
active drug if the hydrophobicity value is less than 
5 (log P ≤ 5) (Lipinski, et al., 1997, Hannahan and 


























Table 1. The molecular docking result of citronellol esters as inhibitor of Pim1 kinase 
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The docking simulation results showed 
that the rerank score of citronellol/geraniol 
esters lower than rerank score of citronellol 
and geraniol. The rerank score is the  minimum 
free energy of the bond between a ligand with 
Pim 1 kinase as a target receptor. The 
minimum energy of binding between 
citronellol/geraniol esters as a ligand to Pim1 
kinase as target receptor were lower than 
minimum energy of binding between 
citronellol/geraniol-Pim1 kinase. It indicated 

















to Pim1 kinase were stronger or more stable 
compared to binding between citronellol and 
geraniol to Pim1 kinase which allows 
inhibiting the performance of Pim 1 kinase in 
causing cancer, so that it will produce a higher 
anticancer activity of citronellol/geraniol esters 
than citronellol and geraniol.  
Based on the minimum energy 
obtained from the docking simulation results, 
the ester compounds have a minimum energy 
lower than reference ligand and have hydrogen 
interaction with the amino acids of an active 
site of protein Pim1 kinase as a target receptor. 
It means ester compounds have potency as 
inhibitor of leukemia cancer cause the 
compounds can inhibit the performance of Pim 
1 kinase. Generally, the minimum energy of 
esters are lower than minimum energy of 
citronellol/ geraniol as starting material and a 
reference ligand of 5H7_401 (A), but higher 
than Artonin E that is a standard chemical 
compound  commonly used in the cytotoxic 
test against murine leukemia (P388) cells. The 
minimum energy of citronellol, geraniol, 
reference ligand and Artonin E were -
130.133,-132.492, -132.239 and -241.419 KJ/ 
mol, respectively.  
The docking resulted in the four top-
ranked compounds, namely, citronellyl 
caproate (CC), citronellyl caprylate (CK), 
geranyl caproate (GC) and geranyl caprylate 
(GK). The rerank scores of binding of these 
compounds to Pim1 kinase were -183.56  to -
189.82 KJ/mol. The docking results also 
showed these compounds have hydrogen 
interaction and steric interaction with amino 
acid residues of active site on Pim1 kinase. 
These compounds have hydrogen interaction 
with  Lys 67 and Asp 186 on active site of 
Pim1 kinase, while the steric interaction with 
Val 52, Leu 120, Asn 172, Asp 186 (CC);  Asn 
172, Ile 104, Leu 174, Val 126, (GC);  Phe 49, 
Ile 104, Val 52 (CK); and Lys 67, Asp 186, 
Phe 187 (GK). The reference ligand have 
hydrogen interaction with amino acid residues 
of Lys 67 and Asp 128 on active site of Pim1 
kinase, and steric interaction with Leu 44,  Arg 
122, Leu 174, and Glu 121, whilts citronellol 
and geraniol have hydrogen interaction with 
amino acid residues of Glu 89 and Phe 187 on 
the catalytic site of Pim1 kinase.  
The interaction of the ligand with Pim 
1 kinases is hydrogen bond between ligand 
such as alkyl group of ester compound or 
hydroxyl groups of alcohol as a ligand with 
amino acids of Pim 1 kinase. The more 
hydrogen bond of ligand-Pim 1 kinase 
indicated by the increasing number of 
hydrogen interaction of ligand-Pim 1 kinase. It 
means the interaction of ligand-Pim 1 kinase 
stronger to inhibit the performance of Pim 1 
kinase in causing cancer. The steric hindrance 
indicated by the steric interaction between 
ligand with amino acids of Pim 1 kinase as a 
receptor will affect the compound as ligand to 
get close and interact with the active side of 
the receptor. Bulky substituents would react 
like hield and encourage the ideal interaction 
between the ligand and the active side of the 
receptor. This substituent will help the 
orientation of the ligand correctly for 
maximum binding of the ligand with the 
receptor thus increasing activity of the ligand, 
but otherwise the steric interaction can also 
give obstruction of space in the process of 
interactions of ligand with receptors. The 
hydrogen bonding interaction of the four top 
ranked compounds to Pim1 kinase as shown in 
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Figure 2.  Hydrogen bonding interaction between Pim1 kinase receptor and citronelly caproate (a), citronelly 
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Table 3. Hydrogen Bond Interaction of CC, CK, GC, and GK with Pim1 Kinase 
 
Compound Interaction with amino acid residues of the protein target  
Pim1 kinase 
Hydrogen interaction Steric interaction 
Citronellyl caproate (CC) Lys 67 Val 52, Leu 120, Asn 172, Asp 186 
Citronellyl caprylate (CK)  Lys 67 Val 52, Phe 49, Ile 104  
Geranyl Caproate (GC) Lys 67 and Asp 186 Asn 172, Ile 104,Leu 174, Val 126 
Geranyl Caprylate (GK) Lys 67 Lys 67, Asp 186, Phe 187 
Noted: RMSD value of all of the compounds of docking results are 0,00 
 
 
Based on the docking results and 
Lipinski’s rule of five, generally the drug 
compound is as orally active drug if the 
hydrophobicity value is less than 5 (log P ≤ 5), 
so that citronellyl caproate (log P = 4.96) and 
geranyl caproate (log P = 4.62) are predicted to 
have potency as a new anticancer candidates 
for possible therapeutic agents. Generally, 
natural ester compounds that have been known 
to have potency as anticancer are a cyclic ester 
or lactone ester such as -lactone 
exomethylene that is a aromatic compound that 
has an oxygen atom in the carbonyl and 
hydroxyl groups that allow the hydrogen bonds 
more with the target amino acid of the protein 
as target receptor thus the interaction more 
stronger to inhibit the performace of the 
receptor in causing cancer. Likewise aromatic 
compounds with amine content which the 
amine group of the compounds allows the 
formation of 3 hydrogen bonds or hydrogen 
interaction thus the bond is stronger in 
inhibiting the performance of protein as target 
receptor in causing cancer. Nevertheless, 
acyclic compounds without amine content such 
as citronellol and geraniol esters that are 
acyclic monoterpene esters to be considered as 
new potential chemopreventive agent for 
cancer. Besides, both of the compounds are 
considered to be synthesized and necessary to 
be cytotoxic activity tested against murine 
leukemia (P388) cancer cells furthermore. To 
increase the potency and selectivity of 
citronellol and geraniol esters as the inhibitors 
of cancer cell proliferation, the molecular 
dynamic simulation of citronellol and geraniol 
ester molecules should be carried out on the 
active side of the Polo Box Domain (PDB) of 
Pim 1 kinase as a receptor to study citronellol 
and geraniol ester interactions to Pim 1 kinase 




Based on molecular docking approach, 
generally citronellol and geraniol ester 
compounds showed the stronger inhibitory 
activity of Pim1 kinase and the greater 
interaction with amino acids residue in the 
catalytic site of Pim1 kinase compared to 
citronellol and geraniol. The docking resulted 
in the four top ranked compounds, namely 
citronellyl caproate, geranyl caproate, 
citronellyl caprylate, and geranyl caprylate. 
Among the four top ranked compounds, 
citronellyl caproate and geranyl caproate that 
are acyclic monoterpene ester compounds 
promising for anti-leukemia cancer agent and 
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